None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Eligible participants will be adults aged 19 years or older with completed jaw growth. Subjects must have one or more missing teeth in the maxilla or mandible and be scheduled for dental implant placement. Only non-smokers will be included in the study. Furthermore, all participants must voluntarily agree to participate in the clinical trial after receiving a full explanation of the study and must provide written informed consent.
Exclusion criteria
Exclusion criteria: The following individuals will be excluded from participation in this study. Pregnant women and those who may become pregnant will not be eligible. Patients with metabolic disorders such as uncontrolled diabetes will be excluded, as well as those taking medications that may affect bone metabolism, including bisphosphonates, recombinant parathyroid hormone (rhPTH), and denosumab. Patients with uncontrolled gingivitis, periodontitis, or severe dental caries will not be included. Subjects with a history of radiotherapy in the surgical site, those with bleeding disorders or requiring anticoagulant therapy, and those with known allergies to dental implant materials will also be excluded. Smokers are not eligible for participation. Additionally, any individual deemed inappropriate for participation by the investigator due to ethical concerns or potential interference with the study results will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the initial implant stability (ISQ values) after immediate placement, comparing SOI and SA surfaces. | — |
Secondary
| Measure | Time frame |
|---|---|
| Monitoring of clinical adverse events (e.g., infection, pain, implant failure) | — |
Countries
Korea, Republic of
Contacts
Ewha Womans University Seoul Hospital